Market Tracker

12/08 5:16pm ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.37
Delayed Data
As of Dec 08
 -0.01 / -0.42%
Today’s Change
2.22
Today|||52-Week Range
7.36
-65.80%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.38
Today’s open2.43
Day’s range2.36 - 2.49
Volume50,002
Average volume (3 months)49,954
Market cap$31.5M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+20.48%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVGNNovogen Ltd-0.03-1.67%
THLDThreshold Pharmaceut...-0.02-3.30%
MBRXMoleculin Biotech In...-0.10-4.00%
AXNAoxing Pharmaceutica...-0.01-1.83%
Data as of 4:02pm ET, 12/08/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts